AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Notice of Dividend Amount May 29, 2025

8900_rns_2025-05-29_81e719dc-f112-466c-b2fc-0410f290fffa.html

Notice of Dividend Amount

Open in Viewer

Opens in native device viewer

Summary Info Kar Dağıtılmaması Hususunda Yönetim Kurulunun Teklifi Hakkında
Update Notification Flag No
Correction Notification Flag No
Postponed Notification Flag No
Decision Date 29.05.2025
Date of Related General Assembly 25.06.2025
Type of Cash Dividend Payment Cash Dividend Will Not Be Paid
Stock Dividend Will Not Be Paid

Cash Dividend Payment Amount and Rates

Share Group Info Payment Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (TL) Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (%) Withholding Rate (%) Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (TL) Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (%)
A Grubu, İşlem Görmüyor, TRETRLC00014 0,0000000 0 0 0,0000000 0
B Grubu, TRILC, TRETRLC00022 0,0000000 0 0 0,0000000 0

Amount and Rate of Cash Dividend Stock Dividend Payment

Share Group Info Amount of Stock Dividend (TL) Rate of Stock Dividend (%)
A Grubu, İşlem Görmüyor, TRETRLC00014 0 0
B Grubu, TRILC, TRETRLC00022 0 0

Additional Explanations

Yönetim Kurulunun 29.05.2025 tarihli kararı ile;

Şirketimizin 2024 yılı faaliyetleri sonucu Sermaye Piyasası Mevzuatına göre hesaplanan 72.358.822-TL dönem kârından (Yasal Kayıtlara Göre 28.499.196,25-TL faaliyet karı vardır) üzerinden hesaplanan 1.424.959,81-TL tutarında Birinci Tertip Yedek Akçe düşüldükten sonra kalan Sermaye Piyasası Mevzuatına göre oluşan 70.933.862,19-TL'lik dönem kârından (Yasal Kayıtlara Göre 27.074.236,44 -TL faaliyet karı vardır) kısmın Geçmiş Yıl Karları/Olağanüstü Yedekler hesabına kaydedilmesine ve bu nedenle kar payı dağıtılmamasına ve bu teklifin yapılacak olan Olağan Genel Kurul toplantısında ortakların onayına sunulmasına ,

karar verilmiştir.

Saygılarımızla.

Supplementary Documents

Appendix: 1 Turk İlaç 2024 Kar Payı Tablosu.pdf

DIVIDEND DISTRIBUTION TABLE

TURK İLAÇ VE SERUM SANAYİ A.Ş. 01.01.2024/31.12.2024 Period Dividend Payment Table (TL)

1.Paid-In / Issued Capital 161.805.000
2. Total Legal Reserves (According to Legal Records) 1.424.959,81
* Based on CMB Regulations Based on Legal Records
3. Current Period Profit 72.358.822 30.611.945,52
4. Taxes Payable (-) 2.112.749 2.112.749,27
5. Net Current Period Profit 70.246.073 28.499.196,25
6. Losses in Previous Years (-)
7. Primary Legal Reserve (-) 1.424.959,81 1.424.959,81
8. Net Distributable Current Period Profit 68.821.113,19 27.074.236,44
Dividend Advance Distributed (-)
Dividend Advance Less Net Distributable Current Period Profit
9. Donations Made During The Year ( + )
10. Donation-Added Net Distributable Current Period Profit on which First Dividend Is Calculated
11. First Dividend to Shareholders
* Cash
* Stock
12. Dividend Distributed to Owners of Privileged Shares
13. Other Dividend Distributed
* To the Employees
* To the Members of the Board of Directors
* To Non-Shareholders
14. Dividend to Owners of Redeemed Shares
15. Second Dividend to Shareholders
16. Secondary Legal Reserves 1.424.959,81 1.424.959,81
17. Statutory Reserves
18. Special Reserves
19. Extraordinary Reserves
20. Other Distributable Resources

Dividend Payment Rates Table

Share Group CASH DIVIDEND AMOUNT (TL) - NET STOCK DIVIDEND AMOUNT (TL) TOTAL DIVIDEND AMOUNT (TL) / NET DISTRIBUTABLE CURRENT PERIOD PROFIT (%) DIVIDEND TO BE PAID FOR SHARE WITH PAR VALUE OF 1 TL - NET (TL) DIVIDEND TO BE PAID FOR SHARE WITH PAR VALUE OF 1 TL - NET (%)
A Grubu 0 0 0 0 0
B Grubu 0 0 0 0 0
TOTAL 0 0 0 0 0

Talk to a Data Expert

Have a question? We'll get back to you promptly.